ambrx
Ambrx And BeiGene To Jointly Develop Next-Gen Biologics
Under the terms of the collaboration with BeiGene, Ambrx will receive US$10 million to fund the initial discovery and research activities for novel biologic drug candidates.
Under the terms of the collaboration with BeiGene, Ambrx will receive US$10 million to fund the initial discovery and research activities for novel biologic drug candidates.
